Quantcast

Latest Hydrocodone Stories

2014-03-28 00:23:11

SAN DIEGO, March 27, 2014 /PRNewswire/ -- We agree with Governor Deval Patrick's intention to curb the epidemic of drug abuse in Massachusetts. However, we are extremely concerned by his unprecedented action with respect to a specific FDA-approved prescription medication. We believe Governor Patrick's ban on Zohydro(TM) ER only serves to unfairly restrict patient access to the only hydrocodone pain reliever available for long-term, daily, severe chronic pain patients who are obtaining relief...

2014-03-25 08:29:44

Drug Store News Group teams with U.S. Pain Foundation to tell the stories of millions of Americans who suffer with chronic pain, and what it means when they are unable to access the medications they need to go about their lives. NEW YORK, March 25, 2014 /PRNewswire-iReach/ -- The Drug Store News Group, the leading provider of news, information and clinical education for the retail pharmacy industry, has launched the new microsite, Drugstorenews.com/pain-management, to help bring...

2014-03-12 08:30:24

Investigational Opioid Analgesic Incorporates Abuse-Deterrent Technology STAMFORD, Conn., March 12, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that a Phase 3 study of an investigational extended-release formulation of hydrocodone bitartrate met its primary efficacy endpoint by showing that patients with chronic low back pain treated with the once-daily analgesic agent experienced statistically significant reduction in pain compared with placebo (p=0.0016). This investigational...

2014-03-04 08:32:42

Composition of Matter Patents Issued in Multiple Countries for KemPharm's Lead Abuse-Deterrent Hydrocodone Prodrug CORALVILLE, Iowa, March 4, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that multiple global composition of matter patents have been issued for KP201 in Russia, Ukraine, Kazakhstan, Japan, Australia, New Zealand and South Africa....

2014-03-03 23:01:04

Staggering prescription drug abuse statistics have caused many to push back against a new painkiller by Zogenix. In partnering with Safer Lock, Zogenix is taking steps to ensure consumer safety and prevent drug abuse while changing the way we approach prescription drug security and distribution. San Diego, CA (PRWEB) March 03, 2014 Today, Zogenix is launching a controversial drug, Zohydro ER. The drug is an extended release pure hydrocodone (pain killer) with no acetaminophen. This...

Zohydro FDA Approval Sparks Concerns From Several Groups
2014-02-26 13:58:12

Lee Rannals for redOrbit.com - Your Universe Online A group of 40 organizations have joined together to try and influence the Food and Drug Administration (FDA) to revoke its approval of the prescription drug Zohydro. The group of health care professionals and consumer and addiction treatment groups say they are “echoing the concerns” of members of Congress and the State Attorneys General regarding the FDA’s decision to approve Zohydro for use. “On behalf of consumer safety...

2014-02-26 08:29:29

CORALVILLE, Iowa, Feb. 26, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that President and CEO, Travis Mickle, Ph.D., will present at the Cowen and Company 34(th) Annual Health Care Conference at the Boston Marriott Copley Place in Boston, MA. Among the topics to be discussed, Dr. Mickle will provide an overview of KemPharm's development pipeline,...

2014-02-05 08:29:57

CORALVILLE, Iowa, Feb. 5, 2014 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today that president and CEO, Travis Mickle, Ph.D., will present at the 16(th) Annual BIO CEO & Investor Conference. Hosted by the Biotechnology Industry Organization (BIO), the 16(th) Annual BIO CEO & Investor Conference will take place February 10-11 at the Waldorf Astoria in New...

2014-01-28 23:29:46

Passages Malibu CEO issues statement on the FDA Approval of Zohydro. Malibu, CA (PRWEB) January 28, 2014 The Food and Drug Administration (FDA) recently approved the sale of Zohydro ER, an extended release version of hydrocodone developed and manufactured by Zogenix. Following that approval, on December 12th 2013, attorneys general from 27 states and the US territory of Guam issued a letter, asking the FDA to reconsider its green light of the drug. A panel hired by the FDA voted 11-2...

2014-01-28 23:03:52

As Morgan & Morgan continues to investigate potential claims on behalf of Tylenol users, the firm is alerting consumers to reports that the FDA has recommended that doctors stop prescribing products with more than 325 mg of acetaminophen per dose. Tampa, FL (PRWEB) January 28, 2014 Morgan & Morgan continues to investigate lawsuits on behalf of Tylenol* users who suffered liver failure, as the FDA announces new recommendations for prescription drugs containing acetaminophen,...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related